Table 1 Baseline characteristics.
Global | Colchicine N = 119 | Control N = 120 | p | |
|---|---|---|---|---|
Age, years | 65.1 ± 16.0 | 66.0 ± 15.5 | 64.2 ± 16.4 | 0.397 |
Sex (male) | 141 (59%) | 70 (59) | 71 (59%) | 0.957 |
Body mass index | 27.5 ± 4.5 | 27.1 ± 4.1 | 27.8 ± 4.7 | 0.255 |
Hypertension | 95 (40%) | 49 (41%) | 46 (38%) | 0.653 |
Dyslipidemia | 78 (33%) | 42 (35%) | 36 (30%) | 0.393 |
Diabetes mellitus | 39 (16%) | 20 (17%) | 19 (16%) | 0.839 |
Smoker | 10 (4%) | 6 (5%) | 4 (3%) | 0.509 |
Coronary artery disease | 16 (7%) | 9(8%) | 7 (6%) | 0.593 |
Heart failure | 6 (3%) | 5 (4%) | 1 (1%) | 0.096 |
Sleep Apnea Syndrome | 6 (3%) | 1 (1%) | 5 (4%) | 0.100 |
Asma | 12 (5) | 4 (3%) | 8 (7%) | 0.242 |
Chronic obstructive pulmonary disease | 10 (4%) | 4 (3%) | 6 (5%) | 0.527 |
Days from the onset of symptoms | 9.0 ± 3.4 | 9.0 ± 3.4 | 9.0 ± 3.4 | 0.954 |
Days from admission | 1.9 ± 1.9 | 2.1 ± 2.3 | 1.6 ± 1.1 | 0.026 |
FiO2 for SatO2 > 90% | 0.30 ± 0.11 | 0.30 ± 0.11 | 0.30 ± 0.12 | 0.911 |
Temperature, °C | 37.3 ± 1.0 | 37.2 ± 1.0 | 37.4 ± 1.0 | 0.347 |
C-reactive protein, mg/dL | 9.8 ± 7.6 | 9.2 ± 6.2 | 10.4 ± 8.8 | 0.230 |
Ferritin, ng/mL | 1203.5 ± 929.2 | 1346.9 ± 1023.6 | 1053.6 ± 796.3 | 0.018 |
D-dimer, mg/L | 1.0 ± 0.8 | 0.9 ± 0.7 | 1.1 ± 0.9 | 0.026 |
Interleukin-6 | 40.1 ± 101.4 | 36.9 ± 62.9 | 43.6 ± 131.1 | 0.635 |
hs-TnT, ng/L | 11.2 ± 16.4 | 11.8 ± 21.0 | 10.6 ± 9.7 | 0.611 |
